What's breaking now, across thousands of outlets.
A delayed clinical trial underscores the stakes of federal research funding cuts for children with DIPG, a deadly brain tumor with few treatment options.
We haven't written up this one. CNBC has the full story — the link below goes straight to it.
A case report in Epidemiology International documents the first confirmed human deaths from Naja oxiana, also called the Central Asian cobra, with two deaths and two survivals recorded in Himachal…
Experts explain why FTD tends to hit earlier in life than other dementias, the often-overlooked signs to know and what care for people with the condition looks like.
PUTRAJAYA, Sept 25 — The Malaysian Anti-Corruption Commission (MACC) will resume recording the statement of Datuk...
A new analysis of longitudinal data reveals a surprising cross-generational connection: mothers whose children excel in math and reading tend to experience better physical and mental health during…
On Dec. 1, Travere Therapeutics will have a new CEO for the first time in almost eight years, as Eric Dube hands the baton to former Amicus Therapeutics CEO Bradley Campbell.
Coupling a fun run with an important free skin screening is a novel way to highlight the importance of early detection.
